Lifecore Biomedical, Inc. (LFCR) Financials
LFCR Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2026 | ? | ? |
| May 31, 2026 | 229.5 million | 213.4 million |
| Feb. 28, 2026 | 225.5 million | 204.7 million |
| Nov. 30, 2025 | 232.2 million | 246.4 million |
LFCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2026 | ? | ? |
| May 31, 2026 | -2.7 million | 2.1 million |
| Feb. 28, 2026 | 3.6 million | 1.7 million |
| Nov. 30, 2025 | -986285 | 5.6 million |
LFCR Net Income
No data available :(
LFCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2026 | - | - | - |
| May 31, 2026 | 17.2 million | 154.1 million | 5.8 million |
| Feb. 28, 2026 | 20.8 million | 142.1 million | 6.7 million |
| Nov. 30, 2025 | 17.5 million | 135.6 million | 6.2 million |
LFCR Shares Outstanding
LFCR Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2026 | - | 1.5 million | 8.0 million | - |
| May 31, 2026 | 513000 | 1.5 million | 8.0 million | - |
| Feb. 28, 2026 | 1.1 million | 1.2 million | 7.9 million | - |
| Nov. 30, 2025 | 1.5 million | 2.3 million | 7.5 million | - |
LFCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2026 | 34.2 million | 22.1 million |
| May 31, 2026 | 34.2 million | 22.1 million |
| Feb. 28, 2026 | 23.2 million | 18.7 million |
| Nov. 30, 2025 | 44.4 million | 28.5 million |
LFCR
Price: $6.38
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.27 USD
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 245.3 million